Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV
NCT ID: NCT06924073
Last Updated: 2025-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1920 participants
INTERVENTIONAL
2025-10-16
2029-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adolescent Transition To Adult Care for HIV-infected Adolescents in Kenya
NCT03574129
Planning the mPACT Trial - mHealth Strategies for the Pediatric to Adult HIV Care Transition
NCT03876483
Adolescent Coordinated Transition Nigerian HIV+ Youth
NCT03152006
Improving HIV Prevention Among Adolescent Girls and Young Women (AGYW) in Uganda
NCT05516602
Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)
NCT01571128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ATP is a healthcare worker (HCW) delivered toolkit that supports the transition from pediatric to independent care for youth living with HIV (YLH). The ATP was developed by the ATTACH study, working in partnership with the Kenya Ministry of Health and other key collaborators leading treatment and care provision in Kenya. The ATP is designed to support transition to adult care for YLH and provide YLH with the knowledge and skills needed to independently manage HIV. The ATP combined two evidence-based interventions from other contexts (Namibia and the United States) and adapted them to better meet Kenyan patient, provider and health system needs. The ATP was tested in a randomized controlled trial of 20 clinics in 4 counties in Kenya (ATTACH study), and shown to significantly improve readiness to transition among YLH in intervention sites compared to those in the control. HCWs and YLH appreciated the content and design of the ATP as they found it feasible and acceptable for routine clinic use.
During this scale up focused R01, the ATP will be administered at the clinic level by existing HCWs during routine YLH clinic visits, as in the original trial. In all participating clinics, all eligible adolescents aged 10-24 years will have medical record data abstracted, and older YLH (ages 15-24) will be offered the opportunity to participate in surveys and qualitative data collection. HCWs from participating clinics will provide feedback on implementation throughout the study and work to optimize delivery of the ATP within their clinic settings.
The ATTACH-Scale study includes implementation of the ATP in 32 clinics. The 32 study sites for this R01 will be selected from a large list of eligible facilities, and specific clinics will be selected by prioritizing high HIV volume clinics (\>50 YLH per clinic), existing collaborations (ex: ATTACH study sites), and MoH priorities. Selection of intervention and control sites will be done using stratified randomization, balancing for county and model of HIV care in the clinic, by a biostatistician based at the University of Washington. The units of analysis vary by study aim, and are either at the level of the HCW, YLH, or clinic, depending on the specific aim and outcome being assessed.
Specific details for each study aim are described below.
Aim 1 (SCALE-UP): Using an effectiveness-implementation hybrid III design, the study will test the impact of ATP scale-up using the Kenya MoH standard of care (SoC) implementation strategy (Trainer of Trainers \[ToT\]) versus an enhanced scale-up implementation strategy that includes the SoC plus youth-led data- driven intervention adaptations (ATP-YES). ATP-YES is a multi-component youth led package that incorporates weekly data assessments, data review and adaptation meetings, and cross collaborative learning across intervention sites. In total, 32 HIV clinics (4 counties, 8 per county) will be randomized 1:1 to 36 months of ATP-YES or SoC alone. The Reach, Effectiveness, Adoption, Implementation and Maintenance \[RE-AIM\] framework will be used to evaluate and compare ATP implementation and guide real-time ATP adaptations. Specifically, ATP reach (YLH exposed to ATP), effectiveness (intervention effect on transition readiness, viral suppression and retention), adoption (proportion of HCWs implementing the ATP), implementation (fidelity to ATP processes), and maintenance (continued use post-trial) will be measured at each study site and compared between intervention and control arms. The Consolidated Framework for Implementation Research (CFIR) will be used to understand the role of context on how and why the ATP-YES strategy is or is not successful. The Framework for Reporting Adaptations and Modifications to Evidence-based Implementation Strategies (FRAME-IS) will be used to systematically study adaptations to the ATP and ATP-YES implementation strategy.
Aim 2 (COSTING): Simultaneously with Aim 1, program costs will be captured and the budget impact of ATP-YES will be compared between intervention and control sites. Micro costing, involving HCW interviews and time and motion observations, will be used to estimate the incremental costs of implementing the ATP-YES strategy and develop a model to project the health impact (HIV deaths and morbidity averted) and financial costs of ATP-YES compared to SoC.
Impact: The study will determine whether the ATP-YES can be used to effectively and affordably support implementation of the ATP in Kenya. The study team hypothesizes that this implementation strategy will improve uptake, integration, and delivery of the ATP within existing YLH clinics.
Alongside study aims, this project will engage communities, build capacity for IS research among youth, program implementers and policy-makers, and participate in collaborative science. The project includes collaboration with MOH in Kenya to ensure transition tools and implementation processes align with and integrate MOH priorities and strategies. The study also includes creation of a youth advisory board and engagement of policy-makers, HCWs, program implementers and other key stakeholders throughout the entirety of the study. Finally, the study supports youth to gain research skills and build capacity for conducting research through their leadership roles in ATP-YES, involvement in youth mentorship programs, and the youth advisory board.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training of trainers
Sites assigned to the standard of care (SoC) control arm will receive cascading training of trainers (ToTs) and cascade training to sites for supporting scale-up of the ATP
No interventions assigned to this group
Youth Enhanced Implementation Strategy (ATP-YES)
Sites assigned to the intervention arm will receive the ATP-YES implementation strategy, a multi-component youth led implementation strategy that incorporates data audits and feedback, cyclical small tests of change and learning collaboratives, to support scale-up of the ATP
ATP-Youth Enhanced Strategy (ATP-YES)
ATP-YES is a multi-component youth led implementation strategy that incorporates data audits and feedback, cyclical small tests of change and learning collaboratives
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ATP-Youth Enhanced Strategy (ATP-YES)
ATP-YES is a multi-component youth led implementation strategy that incorporates data audits and feedback, cyclical small tests of change and learning collaboratives
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥18 years of age
* Employed at one of the 32 facilities in the RCT
* Provides HIV services to adolescents affiliated within their clinic Adolescents and youth living with HIV
* Between 15-24 years of age (focus group discussions, surveys) or between 10-24 years of age (offered the intervention)
* Receives HIV clinical care at one of the clinics included in the study
* Attended clinic ≥1 time following intervention implementation
Exclusion Criteria
\- Conditions that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Kenyatta National Hospital
OTHER_GOV
University of Nairobi, Kenya
UNKNOWN
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristin Beima-Sofie
Senior Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristin M Beima-Sofie, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Irene Njuguna, MBChB, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Kenyatta National Hospital
Grace John-Stewart, MD, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Dalton Wamalwa, MBChB, MMed, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Nairobi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Awendo Sub County Hospital
Awendo, , Kenya
Uriri Sub County Hospital
Awendo, , Kenya
Gatundu Level 5 Hospital
Gatundu, , Kenya
Kiambu County Referral Hospital
Kiambu, , Kenya
Wangige Sub-County Hospital
Kiambu, , Kenya
Kikuyu (PCEA) Hospital
Kikuyu, , Kenya
Nazareth Hospital
Limuru, , Kenya
Arombe Dispensary
Migori, , Kenya
Dede Health Centre
Migori, , Kenya
Migori County Referral Hospital
Migori, , Kenya
St Joseph Mission Hospital (Ombo)
Migori, , Kenya
Baraka Dispensary (Nairobi)
Nairobi, , Kenya
Embakasi Health Centre
Nairobi, , Kenya
Kenyatta National Hospital/University of Nairobi
Nairobi, , Kenya
Mama Lucy Kibaki Hospital
Nairobi, , Kenya
Mbagathi District Hospital
Nairobi, , Kenya
Mukuru Health Centre
Nairobi, , Kenya
Pumwani Maternity Hospital
Nairobi, , Kenya
Tabitha Medical Clinic
Nairobi, , Kenya
Umoja Health Center
Nairobi, , Kenya
Rongo Sub County Hospital
Rongo, , Kenya
Verna Health Centre
Rongo, , Kenya
Ruiru Sub-County Hospital
Ruiru, , Kenya
Kiandutu Health Centre
Thika, , Kenya
Thika Level 5 Hospital
Thika, , Kenya
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00020373
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.